200 related articles for article (PubMed ID: 31445815)
21. Clinical evaluation of commercial PCR assays for antimicrobal resistance in Mycoplasma genitalium and estimation of resistance-mediated mutation prevalence in Moscow and Moscow region.
Shedko ED; Khayrullina GA; Goloveshkina EN; Akimkin VG
Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1413-1418. PubMed ID: 33515097
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of macrolide- and fluoroquinolone-resistant Mycoplasma genitalium strains in clinical specimens from men who have sex with men of two sexually transmitted infection practices in Berlin, Germany.
Dumke R; Ziegler T; Abbasi-Boroudjeni N; Rust M; Glaunsinger T
J Glob Antimicrob Resist; 2019 Sep; 18():118-121. PubMed ID: 31252154
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of Mycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland.
Hokynar K; Hiltunen-Back E; Mannonen L; Puolakkainen M
Int J STD AIDS; 2018 Aug; 29(9):904-907. PubMed ID: 29631509
[TBL] [Abstract][Full Text] [Related]
24. Multiplex Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance Using PlexZyme and PlexPrime Technology.
Tabrizi SN; Tan LY; Walker S; Twin J; Poljak M; Bradshaw CS; Fairley CK; Bissessor M; Mokany E; Todd AV; Garland SM
PLoS One; 2016; 11(6):e0156740. PubMed ID: 27271704
[TBL] [Abstract][Full Text] [Related]
25. Detection of macrolide resistance in Mycoplasma genitalium in France.
Chrisment D; Charron A; Cazanave C; Pereyre S; Bébéar C
J Antimicrob Chemother; 2012 Nov; 67(11):2598-601. PubMed ID: 22773740
[TBL] [Abstract][Full Text] [Related]
26. Macrolide resistance in Mycoplasma genitalium from female sex workers in Belgium.
Coorevits L; Traen A; Bingé L; Descheemaeker P; Boelens J; Reynders M; Padalko E
J Glob Antimicrob Resist; 2018 Mar; 12():149-152. PubMed ID: 28988903
[TBL] [Abstract][Full Text] [Related]
27. Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey.
Salado-Rasmussen K; Jensen JS
Clin Infect Dis; 2014 Jul; 59(1):24-30. PubMed ID: 24729494
[TBL] [Abstract][Full Text] [Related]
28.
Björnelius E; Magnusson C; Jensen JS
Sex Transm Infect; 2017 May; 93(3):167-168. PubMed ID: 27502694
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of rectal Mycoplasma genitalium and macrolide resistance in men who have sex with men attending Sydney Sexual Health Centre.
Bradley I; Varma R; Knight V; Iliakis D; McNally L; Jalocon D; Jeoffreys N; Chen S; McNulty A
Sex Health; 2020 Apr; 17(2):114-120. PubMed ID: 31969248
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia.
Shipitsyna E; Rumyantseva T; Golparian D; Khayrullina G; Lagos AC; Edelstein I; Joers K; Jensen JS; Savicheva A; Rudneva N; Sukhanova L; Kozlov R; Guschin A; Unemo M
PLoS One; 2017; 12(4):e0175763. PubMed ID: 28407014
[TBL] [Abstract][Full Text] [Related]
31. Mycoplasma genitalium in Spain: prevalence of genital infection and frequency of resistance to macrolides.
Asenjo A; Kusters JG; Severs TT; Alós JI
Enferm Infecc Microbiol Clin (Engl Ed); 2018 Mar; 36(3):169-171. PubMed ID: 28291669
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of
Wang L; Li Z; Wan C; Tian X; Liu H; Li Y
Int J STD AIDS; 2023 Jul; 34(8):518-524. PubMed ID: 36929876
[TBL] [Abstract][Full Text] [Related]
33.
Van Praet JT; Steyaert S; Vandecasteele S; Van Den Bergh B; Mahieu H; De Buyser S; Grootaert V; Descheemaeker P; Reynders M
Sex Transm Infect; 2020 Sep; 96(6):396-398. PubMed ID: 31896737
[TBL] [Abstract][Full Text] [Related]
34. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.
Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL
Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013
[TBL] [Abstract][Full Text] [Related]
35. Macrolide resistance in Mycoplasma genitalium in Catalonia, Spain: a 1 year prospective study.
Lucena Nemirosky J; Espelt R; López Grado E; Sobrino J; Acera A; Pérez J; Jensen JS; Sánchez-Reus F; Prim N
J Antimicrob Chemother; 2021 Sep; 76(10):2702-2707. PubMed ID: 34278431
[TBL] [Abstract][Full Text] [Related]
36. Clinical evaluation of the ResistancePlus MG FleXible test on the GeneXpert Infinity-48s instrument: a near-patient assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance.
Fernández-Huerta M; Salmerón P; Silgado A; Espasa M; Pumarola T; Tulsiani-Drud S; Barberá MJ; Hoyos-Mallecot Y; Serra-Pladevall J
Diagn Microbiol Infect Dis; 2020 Aug; 97(4):115062. PubMed ID: 32451118
[TBL] [Abstract][Full Text] [Related]
37. Macrolide-resistant Mycoplasma genitalium infections in Cuban patients: an underestimated health problem.
Mondeja BA; Couri J; Rodríguez NM; Blanco O; Fernández C; Jensen JS
BMC Infect Dis; 2018 Nov; 18(1):601. PubMed ID: 30486786
[TBL] [Abstract][Full Text] [Related]
38. Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis.
Touati A; Peuchant O; Jensen JS; Bébéar C; Pereyre S
J Clin Microbiol; 2014 May; 52(5):1549-55. PubMed ID: 24574291
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS
Lancet Infect Dis; 2020 Nov; 20(11):1302-1314. PubMed ID: 32622378
[TBL] [Abstract][Full Text] [Related]
40. Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014-2017.
Martens L; Kuster S; de Vos W; Kersten M; Berkhout H; Hagen F
Emerg Infect Dis; 2019 Jul; 25(7):1297-1303. PubMed ID: 31211669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
